Anthony G. Quinn
2018
In 2018, Anthony G. Quinn earned a total compensation of $3.8M as Chief Executive Officer at Aeglea BioTherapeutics, a 274% increase compared to previous year.
Compensation breakdown
| Bonus | $304,000 |
|---|---|
| Salary | $507,000 |
| Stock Awards | $2,919,543 |
| Other | $111,591 |
| Total | $3,842,134 |
Quinn received $2.9M in stock awards, accounting for 76% of the total pay in 2018.
Quinn also received $304K in bonus, $507K in salary and $111.6K in other compensation.
Rankings
In 2018, Anthony G. Quinn's compensation ranked 2,924th out of 14,244 executives tracked by ExecPay. In other words, Quinn earned more than 79.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,924 out of 14,244 | 80th |
Division Manufacturing | 1,073 out of 5,759 | 81st |
Major group Chemicals And Allied Products | 371 out of 2,122 | 83rd |
Industry group Drugs | 304 out of 1,811 | 83rd |
Industry Pharmaceutical Preparations | 231 out of 1,385 | 83rd |
Source: SEC filing on April 22, 2019.
Quinn's colleagues
We found two more compensation records of executives who worked with Anthony G. Quinn at Aeglea BioTherapeutics in 2018.
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019